Australia approves Stryker's OP-1 implant
This article was originally published in Clinica
Australia has become the first country to approve for sale Stryker's OP-1 implant for inducing bone formation. The Australian Therapeutic Goods Administration has given the Cambridge, Massachusetts firm the green light to market the implant as a treatment for nonunion of long bone fractures secondary to trauma for the purposes of initiating repair by new bone formation.
You may also be interested in...
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.
Russia says it will make the first deliveries of its $10-per-dose Sputnik V vaccine in January, while international regulators say vaccine trials should continue for as long as possible to generate longer-term evidence on their benefits and risks. A UK research body has stressed that drugs repurposed for COVID-19 also need to undergo thorough safety and efficacy testing as reports suggest the UK regulator could approve a vaccine within days.